ADMA Biologics ADMA Income before provision for income taxes
Income before provision for income taxes at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's income before provision for income taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's income before provision for income taxes?
- ADMA Biologics (ADMA) reported income before provision for income taxes of $57.13M in Q1 2026.
- How has ADMA Biologics's income before provision for income taxes changed year-over-year?
- ADMA Biologics's income before provision for income taxes increased by 70.8% year-over-year, from $33.45M to $57.13M.
- What is the long-term trend for ADMA Biologics's income before provision for income taxes?
- Over 3 years (2022 to 2025), ADMA Biologics's income before provision for income taxes has grown at a 40.5% compound annual growth rate (CAGR), from -$65.9M to $182.66M.
- What does income before provision for income taxes mean?
- This metric represents the total profit or loss generated from core business operations before accounting for income tax expenses. It provides a clear view of the company's operational profitability by excluding the impact of tax jurisdictions and fiscal policies.